“A new HIV-AIDS drug, the first in a promising new class of medications, has been given approval for the Canadian market for treatment when viruses are resistant to other HIV drugs. AIDS expert Dr. Mark Wainberg says there is tremendous optimism about the drug in the community of HIV patients, doctors and researchers.” (Canadian Press)